MarketPulse
R

$RPRX

5 articles found
3 positive
0 negative
2 neutral
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Royalty Pharma Invests $1M Annual Prize to Champion Translational Medicine Breakthroughs

Royalty Pharma launches $1M annual award recognizing translational medicine breakthroughs, to be presented starting spring 2027 at Accelerating Bio-Innovation conference chaired by Nobel Laureate Sir Gregory Winter.
RPRXdrug developmenttranslational medicine
BenzingaBenzinga··Na

Royalty Pharma Maintains Dividend Momentum With $0.235 Q2 Payout

Royalty Pharma declares $0.235 per share dividend for Q2 2026, reinforcing its cash-generative business model across 35+ pharmaceutical products.
RPRXdividendshareholder returns
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Zymeworks Taps Royalty Pharma Executive Stafford as New CFO

Zymeworks appoints Royalty Pharma executive Kristin Stafford as CFO effective April 1, 2026, strengthening financial leadership amid pipeline advancement.
RPRXZYMEcapital allocationCFO appointment
GlobeNewswire Inc.GlobeNewswire Inc.··Not Specified

Vera Therapeutics Bolsters Board with Royalty Pharma Executive Ahead of Key Drug Launch

Vera Therapeutics appoints Christopher Hite, Royalty Pharma EVP, to board as the biotech prepares for atacicept launch in IgA nephropathy treatment.
RPRXVERAbiopharmaceuticalIgA nephropathy
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Royalty Pharma Bets Big on Asia Boom With New Regional Leadership

Royalty Pharma appoints Morgan Stanley veteran Kenneth Sun as SVP to lead Asia expansion, targeting region's surging biotech market and $130B medicine licensing opportunity.
MSMSpAMSpEMSpFMSpI+6Asia expansionnon-dilutive capital